162 related articles for article (PubMed ID: 11324778)
1. Open trial of methotrexate as treatment for autoimmune hearing loss.
Matteson EL; Fabry DA; Facer GW; Beatty CW; Driscoll CL; Strome SE; McDonald TJ
Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
[TBL] [Abstract][Full Text] [Related]
2. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
[TBL] [Abstract][Full Text] [Related]
3. Use of methotrexate for autoimmune hearing loss.
Matteson EL; Tirzaman O; Facer GW; Fabry DA; Kasperbauer J; Beatty CW; McDonald TJ
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):710-4. PubMed ID: 10961801
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients.
Salley LH; Grimm M; Sismanis A; Spencer RF; Wise CM
J Rheumatol; 2001 May; 28(5):1037-40. PubMed ID: 11361185
[TBL] [Abstract][Full Text] [Related]
5. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
7. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
8. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
9. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate therapy for autoimmune hearing loss: a preliminary report.
Sismanis A; Thompson T; Willis HE
Laryngoscope; 1994 Aug; 104(8 Pt 1):932-4. PubMed ID: 8052076
[TBL] [Abstract][Full Text] [Related]
11. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
García Berrocal JR; Ramírez-Camacho R; Arellano B; Vargas JA
Laryngoscope; 2002 Feb; 112(2):304-9. PubMed ID: 11889388
[TBL] [Abstract][Full Text] [Related]
12. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
13. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
Westerlaken BO; de Kleine E; van der Laan B; Albers F
Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
Lasak JM; Sataloff RT; Hawkshaw M; Carey TE; Lyons KM; Spiegel JR
Ear Nose Throat J; 2001 Nov; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
17. Effects of a single intratympanic gentamicin injection on Meniere's disease.
Chung WH; Chung KW; Kim JH; Cho YS; Hong SH
Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM;
Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
[TBL] [Abstract][Full Text] [Related]
20. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
